Raymond James Financial Services Advisors »

Tarsus Pharmaceuticals shares owned by Raymond James Financial Services Advisors

Quarter-by-quarter ownership of Tarsus Pharmaceuticals (TARS) shares owned by Raymond James Financial Services Advisors from 13F filings

Historical chart of Raymond James Financial Services Advisors investment in Tarsus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Tarsus Pharmaceuticals held by Raymond James Financial Services Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tarsus Pharmaceuticals by Raymond James Financial Services Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.9M 51k 36.35
2023-12-31 $887k 44k 20.25
2023-09-30 $545k 31k 17.77
2023-06-30 $305k 17k 18.07

More positions owned by Raymond James Financial Services Advisors

Microsoft Corporation (MSFT)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Vanguard Index Fds Value Etf (VTV)
Home Depot (HD)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Total Stk Mkt (VTI)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Raymond James Financial Services Advisors

Top funds holding Tarsus Pharmaceuticals

Cormorant Asset Management
Tang Capital Management
Cowen And Company
Frazier Life Sciences Management
Vanguard Group
Jennison Associates
Perceptive Advisors
Paradigm Biocapital Advisors
Polygon Management
Ikarian Capital
Vivo Capital
Dimensional Fund Advisors
Artisan Partners Limited Partnership
Nantahala Capital Management
Bank of America Corporation

View all funds holding Tarsus Pharmaceuticals